'Safety data' presentation slideshows

Peripheral & Central Nervous System Drugs Advisory Committee January 28, 2000

1.48k views • 115 slides

Safety in Small to Medium Enterprises

Safety in Small to Medium Enterprises. Sean Mahar, PhD, CIH, CSP, PE. Important legislation. The Health and Safety at Work etc. Act Management of Health and Safety at Work Control of Substances Hazardous to Health The Reporting of Injuries, Diseases and Dangerous Occurrences Regulations

1.16k views • 95 slides

Hazard Communication - Module 4

Hazard Communication - Module 4. S pecial Warehouse Worker Hazards in Structural Steel Fabricating and Supply Companies. Photo from Douglas Steel Fabricating Corporation. Hazard Communication - Module 4. OSHA Grant Information This material was produced under grant number

659 views • 50 slides

Patricia Dinndorf Medical Officer Office of Oncology Drug Products 5/9/07

NDA 022-092 Mifamurtide (MTP-PE) Immuno-Designed Molecules, Inc (IDM) Treatment of High-grade Osteosarcoma in Combination with Chemotherapy. Patricia Dinndorf Medical Officer Office of Oncology Drug Products 5/9/07. Overview of the Presentation.

912 views • 48 slides

FHWA Office of Safety January 25, 2017

Model Inventory of Roadway Elements Fundamental Data Elements: New Requirements Under 23 CFR Part 924. FHWA Office of Safety January 25, 2017. Highway Safety Improvement Program (HSIP) Background. Core Federal-aid program

750 views • 48 slides

INTRODUCTION

671 views • 45 slides

INDUSTRIAL HAZARDS DUE TO FIRE AND MECHANICAL EQUIPMENT

INDUSTRIAL HAZARDS DUE TO FIRE AND MECHANICAL EQUIPMENT. SATYANARAYANA.V ( M.Pharm I sem ) Department Of Pharmaceutical Sciences UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES, KAKATIYA UNIVERSITY, WARANGAL-500609. CONTENTS. INTODUCTION

642 views • 45 slides

Implementation of GHS in New Zealand - approach and practical lessons learned GHS Conference for ASEAN Jakarta, Indone

Implementation of GHS in New Zealand - approach and practical lessons learned GHS Conference for ASEAN Jakarta, Indonesia 9-11 May 2007. Dr Peter Dawson Principal Scientist Environmental Risk Management Authority New Zealand. OUTLINE. Implementation of the GHS in New Zealand

689 views • 36 slides

Exposure at work and protective gloves

Exposure at work and protective gloves. Riitta Jolanki, D.Tech. (Chem.Eng.), Docent Senior Research Scientist, Dermatotoxicologist Finnish Institute of Occupational Health (FIOH) Department of Occupational Medicine Section of Dermatology riitta.jolanki@ttl.fi. Skin hazards at work.

881 views • 35 slides

FDA Perspective

FDA Perspective. Sally Loewke, M.D. Acting Division Director Division of Medical Imaging and Radiopharmaceutical Drug Products CDER/FDA February 3 & 4, 2003. Use of Imaging Drugs in Conjunction with Cardiac Imaging Procedures in the Pediatric Population. Outline. Draft Guidance

465 views • 28 slides

Training Package TP 01/04 Oxygen Deficiency

Training Package TP 01/04 Oxygen Deficiency. Disclaimer

495 views • 25 slides

Intelligent Transportation System (ITS) Highway Safety Data

Intelligent Transportation System (ITS) Highway Safety Data. 2004 Traffic Records Forum SESSION 4 Larry Brown FHWA, Office of Safety July 26, 2004. FHWA Safety Improvement Emphasis. Road Departure Intersections Pedestrian and Bike Safety in Planning Process

676 views • 21 slides

Enrolling Adolescents into Adult Phase 3 Trials

Enrolling Adolescents into Adult Phase 3 Trials. Case Study: Inflammatory Bowel Disease Tara Altepeter, MD Clinical Team Leader Division of Gastroenterology and Inborn Errors Products Office of New Drugs Center for Drug Evaluation and Research. Background.

460 views • 20 slides

Fire Brigades

Fire Brigades. Exits and emergency escape routes. Buildings must have two separate means of exit More exits necessary if greater number of occupants. 1a. Exits and emergency escape routes. Locate so that possibility of blockage is minimized Exits require a safe path of escape. 1b.

381 views • 17 slides

INDEGENE Medical Devices Solutions

INDEGENE Medical Devices Solutions. January, 2018. REAL-WORLD CASE STUDY. 1. Notified Body Submission for CE Approvals. 12+ Resources deployed within 4 weeks. 30% Productivity gained for client. 50+ Documents annually. 100% on Compliance, Timelines & Quality. Outcomes. Business Need.

809 views • 12 slides

262 views • 10 slides

My Carrier Resources, LLC

247 views • 7 slides

Update on the Safety of Erythropoietin Products in Patients With Cancer

Update on the Safety of Erythropoietin Products in Patients With Cancer. May 4, 2004 Robert DeLap, MD, PhD Vice President, Global Regulatory Affairs Johnson & Johnson Pharmaceutical Research & Development. Background Chemotherapy-associated Anemia. Chemotherapy frequently causes anemia

307 views • 7 slides

Request for Additional CTD Guidance

Request for Additional CTD Guidance. Structured approach to integrated clinical summaries/analyses and individual study reports

375 views • 5 slides

Poster # 873 *Sharon Nachman SUNY Stony Brook Stony Brook, NY sharon.nachman@stonybrook

CROI 2010 San Francisco, CA. . . Pharmacokinetic (PK), Safety and Efficacy Data on Cohort IIA; youth aged 6-11 from IMPAACT P1066: A Phase I/II Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth . Poster # 873 *Sharon Nachman SUNY Stony Brook Stony Brook, NY

216 views • 1 slides